Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ClearPoint Neuro Inc (CLPT) vs Novartis AG (NVS) Price & Performance

ClearPoint Neuro IncTrade
Novartis AGTrade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs Novartis AG — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 650.3× ClearPoint Neuro Inc's market cap, and Novartis AG pays a 3.07% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.

CLPTNVS
Market Cap
$454.21M$295.37B
Sector
HealthHealth
52-Week High
$29.60$168.62
52-Week Low
$8.66$119.31
Enterprise Value
$488.79M$336.69B
Dividend Yield
3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS